Status:
RECRUITING
Behavioral AI to Predict and Increase Peritoneal Dialysis Uptake
Lead Sponsor:
Scaled Insights
Collaborating Sponsors:
Dallas Renal Group
The Leeds Teaching Hospitals NHS Trust
Conditions:
Chronic Kidney Disease
Eligibility:
All Genders
18+ years
Brief Summary
Scaled Insights Behavioral AI will be used to improve clinicians ability to detect and understand: The likelihood of patients with kidney failure opting for peritoneal dialysis and to select the right...
Eligibility Criteria
Inclusion
- Phase 1: US and UK adult patients aged 18+ years, with Chronic Kidney Disease stage 4-5.
- Phase 2: US and UK adult patients aged 18+ years, with Chronic Kidney Disease stage 4-5.
Exclusion
- Phase 1: Young people aged \<18 years. People who do not have Chronic Kidney Disease. People who reside outside of the USA and UK.
- Phases 2: Young people aged \<18 years. People who do not have Chronic Kidney Disease stage 4-5. People who reside outside of the USA and UK.
Key Trial Info
Start Date :
September 1 2024
Trial Type :
OBSERVATIONAL
Allocation :
ESTIMATED
End Date :
December 31 2025
Estimated Enrollment :
3000 Patients enrolled
Trial Details
Trial ID
NCT06533254
Start Date
September 1 2024
End Date
December 31 2025
Last Update
December 2 2024
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Dallas Renal Group
Dallas, Texas, United States, 75230